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ABSTRACT 
Objective: To assess the anti-arthritic properties of Balarishta, an Ayurvedic fermented poly herbal product used to combat the immunological 
disorder, Rheumatoid Arthritis which is an autoimmune disease triggered by Proteus urinary tract infection through in silico analysis and assay of 
antimicrobial activity.  
Methods: Antibacterial activity of Balarishta against Proteus mirabilis was assessed. Phytochemical analysis was performed by Gas 
Chromatography-Mass Spectroscopy. Urease interaction proteins were homology modeled based on template constraints and physicochemical 
parameters and stereo chemical nature of the proteins were analyzed. Rigid and flexible docking was done to study the hydrogen bond interaction 
patterns between active ingredients of Balarishta and urease interaction proteins.  
Results: In Balarishta, 42 bioactive metabolites were identified by Gas Chromatography-Mass Spectroscopy analysis. These metabolites were 
checked for strong binding affinities against urease subunits and urease accessory proteins of Proteus mirabilis in silico. ureC subunit exhibited high 
binding to the compound desulphosinigrin (-10.5217 Kcal/mol) followed by lupeol (-10.0308 Kcal/mol) with conserved residue interaction ranging 
from amino acid residues 308 – 327. Further, lupeol when bound to ureC had 4 hydrogen bonds as compared to desulphosinigrin with 6 hydrogen 
bonds. Free energy calculations based on flexible docking showed that lupeol had significant binding affinity for ureC with -9.2 Kcal/mol rather than 
-6.0 Kcal/mol for desulphosinigrin. Both binding has residue conservation - Cys 319, His 320 and His 321. The results corroborated with in vitro 
antibacterial activity.  
Conclusion: It is proposed that Balarishta would be efficient in arresting Rheumatoid Arthritis complicated urinary tract infections. 
Keywords: Ayurveda, Balarishta, Polyherbal fermentation, Urinary Tract Infection, Rheumatoid Arthritis, Proteus mirabilis, Urease proteins, 
Computational Pharmacology, Molecular docking.  
 
INTRODUCTION 
Arishta and Asava are self-generated polyherbal fermented 
medicines of traditional Ayurvedic system. Arishta are made with 
decoctions of herbs in boiling water while Asava are prepared by 
directly using fresh herbal juices. Balarishta is prepared by using 11 
herbal ingredients and the main herb is bala (Sida rhombifolia L.) 
[1]. Balarishta has been traditionally used to treat Rheumatoid 
Arthiritis (RA) by Ayurvedic practitioners [2]. However, there is no 
research on validation of the therapeutic property.  
RA have been categorized by infectious pathogens and have been 
demarcated into six stages.[3]namely, first stage of infection by 
Proteus group of pathogens in which Subclinical UTI’s is caused by 
Proteus sp. That result in asymptomatic bacteriuria[4, 5, 6]. Notably, 
Escherichia coli do not cross react with type XI collagen as they lack 
urease production. E. coli is responsible for 70 – 80% of urinary tract 
infection. Nevertheless, Proteus elicits RA like symptoms by 
producing antibacterial antibodies intended in causing RA [7]. 
Second stage of complication can be possibly attributed to 
antibodies production against Proteus urease and haemolysin in 
local lymph nodes [4]. Thirdly, cytotoxicity targeting hyaline 
cartilage and HLA-DR1/4 positive chondrocytes mimicks the mode 
of action of collagen XI resulting in an enormous accumulation of 
autoantibodies against joint tissues that are rich in collagen [8]. The 
disease progressively damages synovial tissues by macrophage 
infiltration and lymphocyte accumulation leading to release of 
cytokines and chemokines [4]. Stage five comprises of collateral 
damage through secondary cytotoxicity and moreover there will be 
no self / non self recognition as Proteus urease mimicking results in 
diminished activity of TNF-α [4]. Repetitive progress in Proteus 
infection causes recurring inflammation, joint damage, deformities 
and ultimately RA. So, P. mirabilis and its urease are the cause for the 
manifestation of RA. Urease (EC 3.5.1.5) is a nickel containing 
enzyme having its role in nitrogen circulation and was the first 
enzyme that has been crystallized [3]. P. mirabilis urease has a 
molecular weight of about 212 to 250 kDa and is composed of three 
subunit polypeptides, ureA, ureB, and ureC, within the ratio of 2:2:1, 
respectively [9]. Other subunits involved in the present study 
include ureD, ureE, ureF, ureG, ureR, Hns, PMI1793 and pqrA which 
are urease accessory proteins. Hence, the antimicrobial activity of 
Balarishta against P. mirabilis was assessed, its phytochemical 
profile by Gas Chromatography-Mass Spectroscopy (GC-MS) analysis 
was performed and finally the ability of constituent components to 
bind with urease subunits was performed in silico in order to 
validate the ability of Balarishta in treating RA. 
MATERIALS AND METHODS 
Sampling 
The sample was collected from the manufacturing unit of M/S. 
Astanga Ayurvedics (P) Ltd, Tiruchirappalli, Tamilnadu, India.  
Antibacterial activity of Balarishta against Proteus mirabilis 
Urinary as well as enteropathogenic culture namely, Proteus 
mirabilis MTCC425 was obtained from Microbial Type Culture 
Collection, Chandigarh. Air Dried Mueller-Hinton Agar plates (MHA) 
were prepared and the pathogenic organism was inoculated as a 
lawn using sterile swaps. After inoculation, the UTI discs (Himedia 
UTI5 and UTI11) which contain Ampicilin (10µg), Ciprofloxacin 
(5µg), Co-Trimoxazole (25µg), Amoxyclav (30µg), Nitrofurantoin 
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(300µg), Norfloxacin (10 µg), Fosfomycin (200 µg), Amikacin (30 
µg), Gentamycin (10µg), and Ceftriaxone (30µg) that are purchased 
from HI-Media, Mumbai, were placed in the centre of MHA plates. 
After 16-18 hours of incubation, the diameter of zone of inhibition 
were measured and recorded. Similarly, Balarishta sample was also 
tested using the same method. The Balarishta sample was placed in 
a hot air oven at 75ºC for 10 min. to evaporate ethanol in the sample. 
Then 100 µl of the sample was tested by well and disc similar to 
Kirby Bauer method [10]. Ten percent of ethanol (samples contain 
10% of ethanol at the maximum) loaded in disc and well are treated 
as controls. Experiments were performed in triplicates and reported 
as mean ± standard deviation. The relative percentage inhibition of 
the test sample (Balarishta) was calculated using the following 
formula, 100- (X-Y) / (Z-Y) where X = Total area of inhibition of the 
test sample, Y = Total area of inhibition of the solvent, Z = Total area 
of inhibition of the standard antibiotic (The antibiotic exhibiting 
maximum zone of inhibition). The total area of inhibition was 
calculated by using the formula,  where, r = Radius of zone of 
inhibition [11]. 
GC-MS analysis  
Balarishta sample was concentrated and the maximum amount of 
water removed using evaporation in the hot air oven at 80°C for 24-
48 hours before GC-MS (PerkinElmer Clarus 500) analysis. Fifteen 
ml of sample was frozen using deep freezer for one day at - 20°C and 
then, the frozen sample was concentrated with the help of vacuum 
evaporator at – 80°C. The frozen dried sample was dissolved in 10 
ml of HPLC grade methanol and GC-MS analysis was performed. One 
micro liter of sample was injected (split ratio 1:8) into the GC-MS 
system on a 30-m capillary column with a film thickness of 0.25 μm 
(30m x 0.25 mm i. d. coated with 5% Phenyl 
95%dimethylpolysiloxane) using the two types of oven temperature 
were followed to get maximum responses. Helium was the carrier 
gas with flow rate of 1 ml/min. Injection temperature was 280°C. 
Initial oven temperature of 50°C at 10°C/min to 150°C at 8°C/min to 
280°C (10 min*) and then 60°C at 8°C/min to 200°C at 10°C/min to 
300°C(5 min*) were used (Scan type: full scan mode, Scan range: 40-
450 daltons). The peaks are matched with phytochemistry Library: 
NIST (The National Institute of Standards and Technology) MS 
search library version 2.0. 
Homology modeling  
Confidence interval map of urease accessory proteins was analyzed 
from STRING database [12] and availability for authentic structures 
in Protein Data bank was checked comparatively in NCBI Entrez, 
PDB and SWISSPROT databases. The protein sequences for urease 
interaction proteins were retrieved from the STRING database. 
Suitable templates for the above mentioned proteins were selected 
using the homology detection and structure prediction by HMM-
HMM comparison in [13] the templates chosen had an e value <1.0 
and similarity >90%. 
Theoretical Isoelectric point (pI), molecular weight, number of 
positively and negatively charged residues, extinction coefficient, 
Instability Index, Aliphatic Index and Grand average hydropathicity 
(GRAVY) were computed using the Expasy’s protparam server [14]. 
The SOSUI Server [15] was used to characterize whether the protein 
is soluble or transmembrane in nature. Disulphide linkages were 
found by DISULFIND Server.  
Secondary structure was predicted using PSIPRED Server [16]. The 
modeling of the three dimensional structure of the protein was 
performed by MODELLER9V12 [17]. The constructed models were 
energy minimized by CHIMERA [18]. The overall stereochemical 
properties of the proteins were analyzed in the RAMPAGE Server 
[19]. The three dimensional structures were further verified by 
VERIFY3D [20]. RMS-Z score for bond angles of modeled protein 
structure was estimated by QMEAN Server [21]. The models are 
viewed in PYMOL [22]. Ligand binding site and pockets were 
predicted by CASTp Server [23] and QSITE FINDER [24]. 
Preparation of ligands 
The ligand used for the study was downloaded from Pubchem 
project database [25] and Chemspider database [26]. 
 The conversion of SMILES to PDB files was done for generation of 
2D structure of Balarishta active ingredients. RMSD based energy 
minimization was performed in vacou to give a first optimization of 
the rough structure using VEGA ZZ [27]. Hydrogens were initially 
added to receptor molecule, AMBER and gasteiger charges were added 
to fix unusual bonds in the 3D structure which utilizes CHARMM force 
field parameters. The 2D model was optimized and energy minimized 
using clean geometry option in ArgusLab 4.0. [28].  
Docking perspectives 
Docking between urease interaction proteins and active ingredients 
of Balarishta was performed by Patchdock server [29]. Energy 
minimization was performed before and after docking using 
GROMOS96 version of SWISS-PDB Viewer [30]. Hydrogen bond 
interactions were assessed by Discovery studio 3.5. [31] and 
molegro virtual docker [32]. Docked view of the complexes was 
visualized using Pymol. Flexible docking with AUTODOCK VINA 
involving whole protein as the receptor molecule was performed 
and the binding sites were automatically detected [33]. 
RESULTS AND DISCUSSION 
Antibacterial activity  
Antibacterial activity of Balarishta against P. mirabilis were assessed 
in comparison with standard antibiotics in clinically recommended 
dosage (Table 1). It indicates that Ciprofloxacin is most effective 
even at the level of 5µg/disc. Activity of Balarishta is comparable in 
both well method and disc method and it is close to the antibiotic 
Nitrofurantoin (300µg). It implies that Balarishta also have modest 
antibacterial property against Proteus mirabilis.  
However, it was tested at a concentration of 100 µl of Arishta sample 
per disc where the Balarishta is heterogenous with polyherbal 
drugs, ethanol and other ingredients. But the activity of 100 µl of 
Balarishta could match with the pure antibiotic Nitrofurantoin at 
300µg. However, gentamycin (10µg) is most effective against P. 
mirabilis MTCC425 with the highest zone of inhibition. Relative 
percentage inhibition of the test sample (Balarishta, 100 µl/disc) 
when compared with gentamycin is 10.23% only. 
 
Table 1: Antibacterial activity of Balarishta in comparison with 




Proteus mirabilis MTCC425 
(Diameter of zone of inhibition in 
mm) 
Ampicilin (10µg) 25±1.00 
Ciprofloxacin (5µg) 37±0.50 
Co-Trimoxazole (25µg) 26±0.60 
Amoxyclav (30µg) 25±0.53 
Nitrofurantoin (300µg) 13±0.50 
Norfloxacin (10µg) 36±1.00 
Fosfomycin (200µg) 33±0.30 
Amikacin (30µg) 26±0.70 
Gentamycin (10µg) 39±0.90 
Ceftriaxone (30µg) 0±0.00 
Balarishta (100 µl/well) 
Zone of inhibition in well 
method 
12±0.20 
Balarishta (100 µl/disc) 
Zone of inhibition in disc 
method 
12.5±0.50 
(Values are expressed as mean ± standard deviation of the 
triplicates) 
 
GC-MS analysis  
Phytochemical analysis of Balarishta by GC-MS using two different 
temperature programs (Figure 1) indicates the presence of an array 
of phytochemicals (Table 2). There are 42 compounds as per this 
analysis. These compounds were subjected to docking analysis.  
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Fig. 1: GC-MS spectra of Balarishta performed in two different 
oven temperature programs. 
 
Homology modeling  
Figure 2 depicts urease accessory interaction proteins retrieved 
from STRING database. Urease accessory interaction proteins hns, 
pqrA, PMI1793, ureA, ureB, ureC, ureD, ureE, ureF, ureG and ureR 
were modeled using MODELLER 9V12 and was found that out of 11 
proteins five were found stable (Table 3). The stable proteins 
include ureA, ureB, ureC, ureE and ureG. All the proteins were found 
to be soluble in nature. Stability plays a pivotal role in deciphering 
binding affinities, hence stereochemical analysis and RMS-Z score of 
proteins were considered as efficient for categorizing 
conformationally stable proteins and ureC was identified as stable 
from the Ramachandran plot analysis (Figure 3b & 3c). The protein 
ureC had high quality as evident from the number of residues in the 
favourable region (537). Moreover least number of residues in the 
outlier region (3) affirms the above fact. Low RMS-Z score of -4.95 
showed clearly that ureC as an efficient protein for further studies. 
Table 3 depicts the physicochemical parameters of the modeled 
proteins and the qualitative ureC are indicated in red. UreC as 
compared to other proteins has significantly high aliphatic index of 
92.72 and low instability index 36.12 establishing that ureC as a 
stable component when taken in to modeling perspective and 
aliphatic index renders the protein to be of more binding affinity 
patterns. Nevertheless, high amount of positive (66) and negatively 
charged residues (47) also confirm that ureC to be an effective 
interacting partner to other ligands. Figure 3a) illustrates the 
homology modeled structure of ureC with alpha helix pictorially 
shown in yellow, Beta strand in red and coils in green colour. 
Furthermore, Figure 3d) depicts secondary structure patterns of the 
modeled protein. Analysis of pockets and clefts in computed surface 
topology of proteins showed high number of pockets (85) with a 
surface area 5634.6 and volume 13806 for ureC using solvent probe 
of radius 1.4 angstrom (Table 4). Further, DISULFIND results 
affirmed the disulfide bridges with highest (9) cysteine residues for 
ureC (Table 4). Table 5 depicts energy minimization values and ureC 
has a high energy of -9469.724 KJ/mol, Although, ureR has a high 
value than ureC with -9675.076 KJ/mol, due to its low stability 
which is not taken in to account in the present study. Similar study 
by Paramasivan et al involves homology modeling of urease 
accessory interaction proteins of Helicobacter Pylori J 99 and 
predicting an efficient interruption of interaction by Vigna radiata 
defensins showed that ureH and ureI are efficiently abated by VrD1 
and VrD2 defensins [34]. 
Docking perspectives 
Experimental evidence showed that in Proteus mirabilis urease, 
residues 308 to 327 (TVDEHLDMLMVCHHLDPSIP) in large urease 
subunit, ureC, is highly conserved for every urease studied so far and 
has been regarded as active site residues for ureC [9]. 
 
 
Fig. 2: Interaction network of urease interaction proteins. 
 
 
Fig. 3: A) Homology modeled structure of ureC with alpha helix 
shown in yellow, beta sheet in red and coils in green color. B) 
stereochemical nature of the protein ureC. C) Quality of protein 
ureC as predicted by RMSZ score. D) Secondary structure of ureC. 
 
Among the active site residues, ASAVIEW was used to depict the 
nature of amino acid residues and was demarcated in to positive 
charged, negatively charged, polar uncharged, Cysteine residues and 
hydrophobic nature. Analysis revealed that the active site residues 
are hydrophobic rich but are conformationally stable. Figure 4 (a, b, 
c and d) shows the one dimensional and three dimensional images of 
Desulphosinigrin (DSS) and lupeol that were found to interact 
prominently with ureC. Lupeol is a pentacyclic triterpene and was 
found to be anti inflammatory [35] anti arthritic [36], anti 
urolithiatic [37]and hepatoprotective in rats [38]. 
 
Table 2: Chemical compounds identified in Balarishta by GC-MS analysis using two different oven temperature programs. 
S. No. Retention time Name of the chemical compounds 
Temp. 1 Temp. 2  
1. 6.79 6.56 2,4-Dihydroxy-2,5-dimethyl-3(2H)-furan-3-one 
2. 8.29 8.63 2,5-Dimethyl-4-hydroxy-3(2H)-furanone 
3. 10.95 11.41 2-Furancarboxaldehyde, 5-(hydroxymethyl)- 
4. 6.53 6.27 2-Furancarboxaldehyde, 5-methyl- 
5. 4.82 4.34 2-Furanmethanol 
6. 7.11 6.91 2H-Pyran-2,6(3H)-dione 
7 6.18 5.44 2-Propanone, 1,3-dihydroxy- 
8. 9.69 9.90 4H-Pyran-4-one, 2,3-dihydro-3,5-dihydroxy-6-methyl- 
9. 6.02 5.69 6-Oxa-bicyclo[3.1.0]hexan-3-one 
10. - 12.03 α -D-Glucopyranose, 4-O- α -D-galactopyranosyl- 
11. 13.48 - α -D-Glucopyranoside, O- α -D-glucopyranosyl-(1. fwdarw.3)- α -D-fructofuranosyl 
12. 18.67 - Desulphosinigrin 
13. 12.35 13.04 D-Glucose, 4-O- α -D-glucopyranosyl- 
14. - 15.80 d-Glycero-d-ido-heptose 
15. - 5.87 DL-Arabinose 
16. 4.53 4.15 Furfural 
17. - 4.54 Tetrahydropyrrole-3-amino-2,5-dione 
18. 13.96 14.91 Uric acid 
19. 17.98 18.73 Hydrazinecarboxamide, 2-(2-methylcyclohexylidene)- 
20. - 4.01 1,2-Epoxy-3-propyl acetate 
21. 4.62 - 1H-Imidazole-4-ethanamine, N,5-dimethyl- 
22. - 10.27 2(3H)-Furanone, dihydro-4-hydroxy- 
23 3.50 3.15 2,2’-Bioxirane, (R*,R*)-(ñ)- 
.24. 3.93 3.48 2,3-Butanediol 
25. - 6.64 2-Deoxy-D-galactose 
26. 7.21 - 2-Formyl-9-[ α -d-ribofuranosyl]hypoxanthine 
27. 5.69 - (s) 2-Hydroxypropanoic acid 
28. - 2.41 2-Propanone, 1-hydroxy- 
29. 9.51  2-Propanamine, N-methyl-N-nitroso- 
30. 3.39 - 2-Propenoic acid, ethenyl ester 
31. 5.27 - 4-Aminoisoxazolidin-3-one 
32. 11.25 11.20 6-Acetyl- α -d-mannose 
33. - 2.90 Acetic acid, 1-methylethyl ester 
34. 4.09 - Carbonocyanidic acid, ethyl ester 
35. - 21.88 Dibutyl phthalate 
36. 3.22 - Glycerin 
37. 10.03 - Imidazole, 2-amino-5-[(2-carboxy)vinyl]- 
38. - 6.33 Iso-sorbide Dinitrate 
39. 29.62 - Lupeol 
40. - 2.62 Oxirane, 2,3-dimethyl-, trans- 
41. 4.33 - Pentylamine, N-isobutyl-N-nitroso- 
42. - 5.14 R-(-)-1,2-propanediol 
 









(Asp + Glu) 
+ve charged 
residues 







Grand average of 
hydropathicity 
(GRAVY) 
Hns 134 15249.1 5.03 27 22 9970 52.05 85.30 -0.788 
PMI1793 261 30036.4 7.70 31 32 36690 44.10 84.44 -0.333 
pqrA 122 14308.4 9.48 15 21 15595 46.33 73.61 -0.600 
ureA 100 10912.8 5.41 14 12 1615 37.86 104.30 0.102 
ureB 108 12053.8 9.39 13 16 4470 39.93 80.37 -0.394 
ureC 567 60927.0 5.44 66 47 50350 36.12 92.72 0.016 
ureD 274 31008.8 6.31 27 24 53650 42.86 87.55 -0.112 
ureE 161 17887.2 6.03 23 17 13075 31.44 88.39 -0.406 
ureF 222 24992.7 5.41 24 19 51700 48.61 95.41 -0.032 
ureG 205 22300.7 4.96 30 22 9065 23.26 103.71 -0.019 
ureR 293 33415.4 8.15 24 26 23755 40.53 91.16 -0.125 
 
Atomic contact energy values for lupeol - ureC was found to be -
224.86 Kcal/mol, however for DSS- ureC it was -236.53 Kcal/mol. 
Docking with a grid resolution of 0.4 A0 showed that lupeol had a 
docking energy value of -10.0308 Kcal/mol with grid parameter 
value of X, Y, Z = 22.00, 34.25, 25.00 whereas, DSS at the same 
resolution with grid parameter 20.00, 22.75, 25.00 showed an 
increased value of energy ie., -10.5217 Kcal/mol. This binding 
affinity indicated large focused interaction between ureC and 
desulphosigrin compared to lupeol. Comparative analysis of 
Receptor ligand interactions depicts that lupeol with ureC had 
hydrogen bond interactions having Asn307, Thr308 and Glu311 as 
core interacting residues and DSS had Leu 316, Cys 319, His 320 and 
His321 as the pivotal residues at the interface. Figure 5 (a, b, c, d and 
e) depicts the hydrogen bond interactions between docked 
complexes of ureC with DSS and lupeol. The results indicated that 
lupeol has lesser binding affinity than DSS. This may be due to the 
fact that the latter has competitive efficacy with the lupeol. 
Moreover, this report is of its kind in suggesting a therapeutic notion 
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for DSS. The compound had been earlier described as a compound of 
aggravating agent for colon cancer in which it promoted the growth 
of HCT-116 (colon) and NCI H460 (lung) human cancer cells as 
evident from MTT assay at higher concentrations, wherein, µg/ml 
concentrations doubled the growth of HCT-116 colon cancer cells 
and for NCI H460 human lung cancer cells, DSS at 60μg/ml showed 
an increase in the cell number by 20% [39]. The above literature 
could be the only authentic citation that DSS has biological activity. 
Moreover, any component at a higher concentration may be 
deleterious. Hence, in the years to come we suggest that DSS could 
be a provocative agent in UTI therapeutics in a concentration 
dependent manner.  
Antioxidant potentials of lupeol have been a largely studied arena in 
the case of hepatotoxicity [38] Arbitrarily, DSS acting as anti-UTI 
pharmaceuticals could invoke major clinical side effects, Hence we 
hypothesize that upon reduced concentrations DSS can have 
profound implications in treatment of UTI’s. On the contrary, 
significant hepatoprotectivity by lupeol has its major role in lipid 
peroxidation wherein, peroxyl radicals scavenging is the main 
modality of anti oxidant property of lupeol [38], DSS doesn’t have 
activity on lipid peroxidation at 250g/ml [39]. Binding energy values 
from flexible docking by AUTODOCK VINA showed that lupeol has an 
increased free energy of -9.2 Kcal/mol when compared to DSS which 
has -6.0 Kcal/mol (Figure. 6). 
 
Table 4: Pockets and cysteine residues in the modeled proteins 
Name of the protein Pocket Area Volume Cysteine residues 
hns 14 127.6 178.2 - 
PMI1793 48 651.8 1067.5 4 
pqrA 19 318.5 787.1 2 
ureA 17 263.1 370.6 2 
ureB 21 97.9 197.8 - 
ureC 85 5634.6 13806 9 
ureD 50 652.1 836.1 5 
ureE 22 883.6 2444 3 
ureF 37 260 351.4 4 
ureG 33 222.5 310.8 2 
ureR 54 1346.3 1735.3 6 
 
Table 5: Energy minimization values obtained for modeled 
proteins. 














Fig. 4: A) and B) Three dimensional and one dimensional views 
of Desulphosinigrin respectively. C) and D) Three dimensional 
and one dimensional views of lupeol respectively. 
 
Fig. 5: A) Hydrogen bond interactions between 
desulphosinigrin and ureC. B) Hydrogen bond interactions 
between lupeol and ureC. C) Hydrogen bond interactions 
between of desulphosinigrin and ureC based on Ligplot. D) 
Hydrogen bond interactions between of lupeol and ureC based 
on Ligplot. E) Three dimensional views of interactions among 
ureC, desulphosinigrin (Green) and lupeol (Yellow). 
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Fig. 6: A) and B) Flexible docking results for desulphosinigrin. 
C) and D) Flexible docking results for lupeol 
 
Further, Cys319, His320, and Ala167 contribute to catalysis of urea 
and was affirmed based on molecular dynamics simulations [40]. 
Dinickel binding on comparison with hydrogen bonding have been 
emancipated earlier that urease inhibitors are mostly conserved in 
structural conformation based on the binding motif that flaps the 
prominent orientation of the protein. To the core, nickel binding by 
tetrahedral coordination have been largely attributed for strong 
urease inhibition by urease inhibitors like diamidophosphate and 
I3A [40]. Future directions of research will be thrusted upon 
dinickel binding to lupeol. Therefore, there is every possibility of 
competitive inhibition of DSS activity by lupeol. Furthermore, 
abatement of RA by Balarishta has been traditionally documented in 
Ayurveda, a deep insight in to its molecular dissection of activity 
particularly with reference to UTI is still lacking. The present study 
would abridge the above gap and enhance insights in to 
antimicrobial properties of Balarishta and will have prominent 
impact in the field of complimentary therapies and alternative 
medicine.  
CONCLUSIONS 
UTI complicating RA has been regarded as a medical menace. Urease 
and its accessory interaction proteins are key virulent factors 
causing the infection. The present study addresses the issue by 
antibacterial activity assay against the causative agent, P. mirabilis 
and assessing the phytochemical components by GC-MS analysis. 
Further computational studies pertaining to homology modeling and 
docking of the phytochemicals were performed. DSS and lupeol were 
found to interact efficiently with ureC suggesting its role in 
therapeutic perspectives. Here, Hydrogen bond interactions rather 
than dinickel binding showed significant interactions. We further 
hypothesize that lupeol competitively binds to ureC in eliciting anti 
oxidant activities through lipid peroxidation. Hence, it is 
confirmative that lupeol apart from dinickel binding can elicit a 
protective response based on hydrogen bond affinities.  
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